These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8575148)

  • 1. Transient osteoporosis of the hip: successful response to deflazacort.
    Carmona-Ortells L; Carvajal-Méndez I; García-Vadillo JA; Alvaro-Gracia JM; González-Alvaro I
    Clin Exp Rheumatol; 1995; 13(5):653-5. PubMed ID: 8575148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic transient osteoporosis of the pelvis in a non-pregnant young woman: a case study.
    Escolà A; Pons M; Pasarin A; Majó J
    Hip Int; 2009; 19(1):71-4. PubMed ID: 19455507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcitonin in the treatment of transient osteoporosis of the hip.
    Arayssi TK; Tawbi HA; Usta IM; Hourani MH
    Semin Arthritis Rheum; 2003 Jun; 32(6):388-97. PubMed ID: 12833247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Transient osteoporosis of the hip in pregnancy. Successful treatment with calcitonin: a case report].
    Laktasic-Zerjavic N; Curkovic B; Babic-Naglic D; Potocki K; Prutki M; Soldo-Juresa D
    Z Rheumatol; 2007 Oct; 66(6):510-3. PubMed ID: 17849129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deflazacort for long-term maintenance of remission in type I autoimmune hepatitis.
    Rebollo Bernárdez J; Cifuentes Mimoso C; Piñar Moreno A; Caunedo Alvarez A; Salas Herrero E; Jiménez-Sáenz M; Herrerías Gutiérrez J
    Rev Esp Enferm Dig; 1999 Sep; 91(9):630-8. PubMed ID: 10502711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deflazacort.
    Joshi N; Rajeshwari K
    J Postgrad Med; 2009; 55(4):296-300. PubMed ID: 20083885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Glucocorticoids and risk of osteoporosis. On the problem of equivalent dose of desirable and undesirable effects of various glucocorticoids, exemplified by deflazacort].
    Rotenberger J; Köbberling J
    Med Klin (Munich); 1993 Jul; 88(7):432-7. PubMed ID: 8377721
    [No Abstract]   [Full Text] [Related]  

  • 8. Deflazacort in pediatric rheumatic diseases needs a frequent follow-up of bone densitometry.
    Falcini F; Trapani S; Ermini M; Bartolozzi G
    Pediatrics; 1995 Feb; 95(2):318. PubMed ID: 7838659
    [No Abstract]   [Full Text] [Related]  

  • 9. A longterm prospective study of the equipotency between deflazacort and prednisolone in the treatment of patients with polymyalgia rheumatica.
    Krogsgaard MR; Lund B; Johnsson B
    J Rheumatol; 1995 Sep; 22(9):1660-2. PubMed ID: 8523341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of low doses of deflazacort vs prednisone on bone mineral content in premenopausal rheumatoid arthritis.
    Messina OD; Barreira JC; Zanchetta JR; Maldonado-Cocco JA; Bogado CE; Sebastián ON; Flores D; Riopedre AM; Redondo G; Lázaro A
    J Rheumatol; 1992 Oct; 19(10):1520-6. PubMed ID: 1464862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary experience with deflazacort, a new synthetic steroid with fewer undesirable side effects, in heart transplant patients.
    Arizón JM; Anguita M; Vallés F; Montero A; Sancho M; López-Rubio F; Latre JM; Calleja F; Casares J; Román M
    J Heart Lung Transplant; 1993; 12(3):445-8; discussion 448-9. PubMed ID: 8329416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of deflazacort, a glucocorticoid with bone-sparing properties, on mixed lymphocyte response and skin graft rejection.
    Mistrello G; Mapelli E; Galliani G; Cristina T; Assandri A
    Transplantation; 1984 Aug; 38(2):192-4. PubMed ID: 6235649
    [No Abstract]   [Full Text] [Related]  

  • 13. The ghost joint: transient osteoporosis of the hip.
    Bruinsma BJ; LaBan MM
    Arch Phys Med Rehabil; 1990 Apr; 71(5):295-8. PubMed ID: 2327879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient osteoporosis of the hip.
    Mirza R; Ishaq S; Amjad H
    J Pak Med Assoc; 2012 Feb; 62(2):196-8. PubMed ID: 22755396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful neridronate therapy in transient osteoporosis of the hip.
    La Montagna G; Malesci D; Tirri R; Valentini G
    Clin Rheumatol; 2005 Feb; 24(1):67-9. PubMed ID: 15322945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, double-blind trial of deflazacort versus prednisone in juvenile chronic (or rheumatoid) arthritis: a relatively bone-sparing effect of deflazacort.
    Loftus J; Allen R; Hesp R; David J; Reid DM; Wright DJ; Green JR; Reeve J; Ansell BM; Woo PM
    Pediatrics; 1991 Sep; 88(3):428-36. PubMed ID: 1881719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of hydrocortisone versus deflazacort in drug-resistant epilepsy of childhood.
    Grosso S; Farnetani M; Mostardini R; Cordelli D; Berardi R; Balestri P
    Epilepsy Res; 2008 Sep; 81(1):80-5. PubMed ID: 18524542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-modality imaging of transient osteoporosis of the hip.
    Gemmel F; Van Der Veen HC; Van Schelven WD; Collins JM; Vanneuville I; Rijk PC
    Acta Orthop Belg; 2012 Oct; 78(5):619-27. PubMed ID: 23162958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deflazacort versus methylprednisolone in polymyalgia rheumatica: clinical equivalence and relative antiinflammatory potency of different treatment regimens.
    Di Munno O; Imbimbo B; Mazzantini M; Milani S; Occhipinti G; Pasero G
    J Rheumatol; 1995 Aug; 22(8):1492-8. PubMed ID: 7473472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized study comparing deflazacort and prednisone in heart transplant patients.
    Arizón JM; Anguita M; Vallés F; López-Rubio F; López-Granados A; Casares J; Segura J; Mesa D; Muñoz I; Alados P
    J Heart Lung Transplant; 1993; 12(5):864-8. PubMed ID: 8241229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.